CHG

525

+1.35%↑

CHG

525

+1.35%↑

CHG

525

+1.35%↑

CHG

525

+1.35%↑

CHG

525

+1.35%↑

Search

Halma PLC

Gesloten

SectorIndustrieën

3,644 -1.67

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3642

Max

3648

Belangrijke statistieken

By Trading Economics

Inkomsten

107M

187M

Verkoop

651M

1.2B

K/W

Sectorgemiddelde

39.517

49.893

EPS

0.553

Dividendrendement

0.64

Winstmarge

15.096

Werknemers

9,000

EBITDA

184M

317M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+3.24% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

0.64%

2.04%

Volgende dividenddatum

30 jan 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-212M

14B

Vorige openingsprijs

3645.67

Vorige sluitingsprijs

3644

Nieuwssentiment

By Acuity

29%

71%

80 / 408 Rangschikking in Industrials

Halma PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 jan 2026, 23:49 UTC

Marktinformatie

Oil Falls on Possible Technical Correction -- Market Talk

25 jan 2026, 23:43 UTC

Marktinformatie

Correction to Gold Rises Above $5000/oz Market Talk

25 jan 2026, 23:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

25 jan 2026, 23:43 UTC

Marktinformatie

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

25 jan 2026, 23:36 UTC

Marktinformatie

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Companies Had Been Discussing Roughly $30B Deal -- WSJ

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

24 jan 2026, 09:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

24 jan 2026, 09:20 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

24 jan 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

24 jan 2026, 09:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

24 jan 2026, 06:18 UTC

Acquisities, Fusies, Overnames

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

23 jan 2026, 22:30 UTC

Marktinformatie

Global Equities Roundup: Market Talk

23 jan 2026, 22:30 UTC

Marktinformatie

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

23 jan 2026, 22:03 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 jan 2026, 21:52 UTC

Winsten
Acquisities, Fusies, Overnames

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

23 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

23 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

23 jan 2026, 21:39 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

23 jan 2026, 21:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

23 jan 2026, 21:12 UTC

Winsten

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

23 jan 2026, 20:31 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

23 jan 2026, 20:12 UTC

Marktinformatie

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

23 jan 2026, 20:07 UTC

Marktinformatie

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

23 jan 2026, 19:36 UTC

Marktinformatie

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

23 jan 2026, 19:30 UTC

Marktinformatie
Winsten

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

23 jan 2026, 19:18 UTC

Marktinformatie

Gold and Silver Step Up to More Records -- Market Talk

Peer Vergelijking

Prijswijziging

Halma PLC Prognose

Koersdoel

By TipRanks

3.24% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 3,755.75 GBX  3.24%

Hoogste 4,200 GBX

Laagste 2,490 GBX

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halma PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

13 ratings

7

Buy

5

Hold

1

Sell

Sentiment

By Acuity

80 / 408 Rangschikking in Industrieën

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat